Company Profiles

driven by the PitchBook Platform

APT Therapeutics

Description

Developer of antiplatelet therapy designed to transform human apyrase into life saving medicine. The company's antiplatelet therapy uses protein engineering, protein informatics and cheminformatics software to create base therapeutics and molecule drugs for acute myocardial infarction, stroke and transplantation complications, enabling patients to get minimally damaged when there is a heart attack.

2001

Founded

PRIVATE

Status

Grant

Latest Deal Type

$6.35M

Latest Deal Amount

$3.68M

Total Amount Raised

5

Investors

Description

Developer of antiplatelet therapy designed to transform human apyrase into life saving medicine. The company's antiplatelet therapy uses protein engineering, protein informatics and cheminformatics software to create base therapeutics and molecule drugs for acute myocardial infarction, stroke and transplantation complications, enabling patients to get minimally damaged when there is a heart attack.

Website:

www.apt-therapeutics.com

Formerly Known As

Advanced Protein Technologies

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Biotechnology

Primary Office

4041 Forest Park Avenue Saint Louis, MO 63108-2211United States +1 (314) 800-4742
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore APT Therapeutics's full profile, request a free trial.

APT Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

APT Therapeutics Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioGeneratorNot-For-Profit Venture CapitalMinority000 0000000 0000
CID EquityVenture CapitalMinority000 0000000 0000
Nidus Center for Scientific EnterpriseAccelerator/IncubatorMinority000 0000000 0000
Prolog VenturesAccelerator/IncubatorMinority000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
BioGenerator Not-For-Profit Venture Capital
CID Equity Venture Capital
Nidus Center for Scientific Enterprise Accelerator/Incubator
Prolog Ventures Accelerator/Incubator
U.S. Department of Health and Human Services Government

APT Therapeutics Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Ridong Chen Ph.DCo-Founder, President & Chief Executive Officer
Ridong Chen Ph.D Co-Founder, President & Chief Executive Officer

APT Therapeutics Board Members (2)

NameRepresentingRoleSinceContact
Info
Brian Clevinger Ph.DProlog VenturesManaging Director000 0000
Eric Gulve Ph.DBioGeneratorPresident000 0000
Brian Clevinger Ph.D Managing Director Prolog Ventures
Eric Gulve Ph.D President BioGenerator
Request full access to PitchBook